- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02639611
Effectiveness of Acupuncture in Post-Mastectomy Patients With Tissue Expanders
August 2, 2016 updated by: NYU Langone Health
The primary purpose of this study is to evaluate changes in shoulder tightness, chest tightness, and general pain related to post-mastectomy reconstructive surgery with tissue expansion in women who are randomized to receive acupuncture treatment immediately after surgery (twice a week for 6 weeks) compared to those who are randomized to no acupuncture treatment for 6 weeks, but offered acupuncture at the end of the 6 week study period.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 79 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women who are newly diagnosed with breast cancer, enrolled in the The Breast Cancer Database of NYU Cancer Center (BCD) and who are having breast cancer surgery involving a mastectomy procedure with insertion of a tissue expander for reconstructive purposes
- Women who are newly diagnosed with breast cancer
- Women who are enrolled in the Breast Cancer Database (BCD)
- Women who are having breast cancer surgery involving a mastectomy procedure with insertion of a tissue expander for reconstructive purposes
Exclusion Criteria:
- Women who had neoadjuvant chemotherapy and/or radiation therapy, women who are currently on anticoagulant therapy, women who are having breast reconstruction with Alloderm, women who have chronic pre-operative pain, and/or women who have had a history of previous implants or prior augmentations
- Women who had neoadjuvant chemotherapy and/or radiation therapy
- Women who are currently on anticoagulant therapy
- Women who are having breast reconstruction with Alloderm
- Women who have chronic pre-operative pain
- Women who have had a history of previous implants or prior augmentations
- Women who are currently on anticoagulant therapy
- Women who are having breast reconstruction with Alloderm
- Women who have chronic pre-operative pain
- Women who have had a history of previous implants or prior augmentations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Immediate Post Operative Acupuncture Treatment
|
acupuncture treatment immediately after surgery (twice a week for 6 weeks)
|
|
ACTIVE_COMPARATOR: Acupuncture Treatment After 6 Weeks of Recovery
|
no acupuncture treatment for 6 weeks, but offered acupuncture at the end of the 6 week study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Shoulder Tightness Score on Pain and Discomfort Assessment Questionnaire
Time Frame: 6 Weeks
|
6 Weeks
|
|
Chest Tightness Score on Pain and Discomfort Assessment Questionnaire
Time Frame: 6 Weeks
|
6 Weeks
|
|
General Pain Score on Pain and Discomfort Assessment Questionnaire
Time Frame: 6 Weeks
|
6 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Freya Schnabel, MD, New York University Medical School
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2013
Primary Completion (ACTUAL)
February 1, 2016
Study Registration Dates
First Submitted
December 22, 2015
First Submitted That Met QC Criteria
December 22, 2015
First Posted (ESTIMATE)
December 24, 2015
Study Record Updates
Last Update Posted (ESTIMATE)
August 3, 2016
Last Update Submitted That Met QC Criteria
August 2, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 12-03266
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Immediate Post Operative Acupuncture Treatment
-
Khoo Teck Puat HospitalMinistry of Health, SingaporeActive, not recruitingHip Fracture Surgeries | Post-operative Hip Fractures RecoverySingapore
-
University Hospital, ToulouseRecruitingIdiopathic Scoliosis | ERASFrance
-
National Center for AIDS/STD Control and Prevention...AbbVie; Guangxi Center for Disease Control and PreventionUnknownAcquired Immunodeficiency Syndrome | HIVChina
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South KoreaCompletedStage I Breast Cancer | Stage II Breast Cancer | Early-Stage Breast Carcinoma | Stage III Breast Cancer | Chemotherapy-induced Peripheral Neuropathy (CIPN) | Taxane-induced Peripheral NeuropathyUnited States
-
Bangor UniversityBetsi Cadwaladr University Health BoardCompleted
-
Ente Ospedaliero Cantonale, BellinzonaRecruitingLateral Malleolus FractureSwitzerland
-
Universidade Católica PortuguesaDanilo FernandesCompleted
-
Cara Therapeutics, Inc.CompletedAcute PainUnited States
-
Hacettepe UniversityCompletedScoliosis Idiopathic | Scoliosis; AdolescenceTurkey
-
Eastern Mediterranean UniversityCompletedObesity | Bariatric Surgery Candidate | Healthy Eating IndexCyprus